Insys Therapeutics (INSY) Jumps as Epinephrine Nasal Spray Shows Early Promise for Anaphylaxis
Tweet Send to a Friend
INSYS Therapeutics, Inc. (NASDAQ: INSY) is gaining 18% intra-day after the company announced that its investigational epinephrine nasal spray showed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
